Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)-Direct Plan

16.56 0.18 (1.10%) NAV as on 20-Apr-21
52-Week High ( ) 16.56 (20-Apr-21)
52-Week Low ( ) 12.10 (19-May-20)
Type Open ended scheme
Launch Date 10-Jul-19
Net Assets ( Cr ) 454.91
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 1000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return17.7048.02NA39.42
Category Avg17.2253.9321.9924.26
Category Best-0.765.063.2019.46
Category Worst-6.89-3.39-6.39-4.00
SENSEX17.6650.7411.50-
NIFTY20.1754.3610.61-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Sun Pharmaceutical Industries Ltd.Domestic Equities11.12
Dr. Reddys Laboratories Ltd.Domestic Equities9.77
Cipla Ltd.Domestic Equities9.22
Divis Laboratories Ltd.Domestic Equities8.63
Lupin Ltd.Domestic Equities7.98
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equities & Equity Linked instruments of comp in the Pharma & Healthcare sec80100
Other Equities & Equity Linked instruments020
Debt and Money Market Instruments020
Units issued by REITs & InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 20/04/2021 As on 20/04/2021

14296.40 (-0.44) 47705.80 (-0.51)

TOP GAINERS

Company Price Change Gain (%)
Everest Kanto Cylind110.7018.4520.00
Maheshwari Logistics106.9017.8019.98

TOP LOSERS

Company Price Change Loss (%)
LCC Infotech2.70-0.30-10.00
Suvidhaa Infoserve48.35-5.35-9.96

Portfolio Comparison

MUTUAL FUND ACTIVITY